Horizon Genomics Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Horizon Genomics General Information

Description

Provider of biotechnological services. The company specializes in managing human cell products such as haploid human cell lines used to generate model cell lines for functional genomics studies.

Contact Information

Formerly Known As
Haplogen Genomics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Campus Vienna Biocenter 5
  • Vienna, 1030
  • Austria
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Horizon Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Horizon Genomics‘s full profile, request access.

Request a free trial

Horizon Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biotechnological services. The company specializes in managing human cell products such as haploid human cel
Biotechnology
Vienna, Austria
11 As of 2015
00.00 0000-00-00
000000&0

00000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000000

or sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000000
Seoul, South Korea
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Horizon Genomics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Egenesis Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 Corporation Seoul, South Korea 00
0000000 0000000000 Venture Capital-Backed Berkeley, CA 00 00000 00000000000 00000
00000000 000000000 Formerly VC-backed Cambridge, MA 000 0000 000000 - 000 0000
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Horizon Genomics Executive Team (2)

Name Title Board Seat Contact Info
Darrin Disley Ph.D Co-Chief Executive Officer
Thomas Moser Ph.D General Manager
To view Horizon Genomics’s complete executive team members history, request access »

Horizon Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial